Septerna Inc SEPN · News

123

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled rec...

Price50.74

Market Cap2.37 B

Float19.55 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Search in Documents